[Human pharmacology of carteolol].
D000284:Administration, Oral; D001792:Blood Platelets / Q000187:drug effects; D002354:Carteolol / Q000494:pharmacology* / Q000627:therapeutic use; D003327:Coronary Disease / Q000188:drug therapy; D006439:Hemodynamics / Q000187:drug effects*; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D007275:Injections, Intravenous; D008297:Male; D010869:Pindolol / Q000494:pharmacology; D011412:Propanolamines / Q000494:pharmacology*; D011433:Propranolol / Q000494:pharmacology; D013375:Substance Withdrawal Syndrome / Q000503:physiopathology
D011412:Propanolamines; D002354:Carteolol; D011433:Propranolol; D010869:Pindolol
Zur Humanpharmakologie von Carteolol.